Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cetuximab (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Epidermal growth factor receptor inhibitor |
Inferred relationship |
Some |
|
Epidermal growth factor receptor inhibitor |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Epidermal growth factor receptor inhibitor |
Inferred relationship |
Some |
|
Panitumumab (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Epidermal growth factor receptor inhibitor |
Inferred relationship |
Some |
|
Necitumumab (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Epidermal growth factor receptor inhibitor |
Inferred relationship |
Some |
|
Osimertinib (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Epidermal growth factor receptor inhibitor |
Inferred relationship |
Some |
|
Osimertinib mesilate (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Epidermal growth factor receptor inhibitor |
Inferred relationship |
Some |
|
Nimotuzumab (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Epidermal growth factor receptor inhibitor |
Inferred relationship |
Some |
|
Gefitinib (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Epidermal growth factor receptor inhibitor |
Inferred relationship |
Some |
|
Erlotinib hydrochloride (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Epidermal growth factor receptor inhibitor |
Inferred relationship |
Some |
|
Erlotinib (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Epidermal growth factor receptor inhibitor |
Inferred relationship |
Some |
|
Lapatinib (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
False |
Epidermal growth factor receptor inhibitor |
Inferred relationship |
Some |
|
Lapatinib ditosylate (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Epidermal growth factor receptor inhibitor |
Inferred relationship |
Some |
|
Vandetanib (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Epidermal growth factor receptor inhibitor |
Inferred relationship |
Some |
|
Lapatinib ditosylate monohydrate (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Epidermal growth factor receptor inhibitor |
Inferred relationship |
Some |
|
Human epidermal growth factor receptor 2 inhibitor |
Is a |
True |
Epidermal growth factor receptor inhibitor |
Inferred relationship |
Some |
|
Amivantamab (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Epidermal growth factor receptor inhibitor |
Inferred relationship |
Some |
|
Lapatinib ditosylate anhydrous |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Epidermal growth factor receptor inhibitor |
Inferred relationship |
Some |
|